Legeviten > Pediatri
Scientists draw from wristwatches, wireless transmission technology, and patients’ own heartbeats to design new power sources.
(The Scientist)
[09.06.2017 17:47]
Hva spesialiserer jeg meg som, hvis jeg som lege vil jobbe med spedbarn?
Les mer »
Jeg har planer om å studere medisin, og bli lege.
(Ung.no - offentlig informasjon for ungdom) |
The 'Jimmy Kimmel Test': A Way for the GOP to Save Healthcare.
Les mer »
Talk show host offers insight for Republican lawmakers.
(MedPage Today) |
PrairieCare gets green light to add beds at Brooklyn Park psychiatric hospital.
Les mer »
Adding second beds to 21 patient rooms at a child psychiatric hospital in Brooklyn Park would address a continued shortage of mental health services, the Minnesota Department of Health concluded.
(www.startribune.com) |
Pain Shouldn't Be Part of Kids' Cancer Treatment.
Les mer »
Must address young patients' suffering from the start of care.
(MedPage Today) |
Obese Kids Lose Weight with Multipronged Approach.
Les mer »
Combo of clinical, family, and community support offers long-term results.
(MedPage Today) |
Novel Agent Shows Antitumor Activity in TRK-Fusion Cancers.
Les mer »
Tumor genetics define treatment approach in early-stage trials.
(MedPage Today) |
Trond Markestad utnevnt som æresmedlem av NBF 2017.
Les mer »
Trond Markestad er utnevnt som æresmedlem i NBF for sitt mangeårige arbeid innenfor pediatri som har satt dype spor både nasjonalt og internasjonalt. Les utfyllende omtale under.
(Den norske l?geforening) |
Torstein Vik utnevnt som æresmedlem av NBF i 2017.
Les mer »
Torstein Vik er utnevnt som æresmedlem av NBF i 2017. Han har gjennom et langt yrkesliv betydd svært mye for utviklingen av norsk pediatri, kanskje aller mest innen forskning og undervisning. Les hele omtalen under.
(Den norske l?geforening) |
Eight Presentations at ASM Microbe Include Late Breaker From Cempras Phase 3 Fusidic Acid Study and Solithromycin Data on Gonorrhea and Otitis Media.
Les mer »
?We are pleased that ASM has recognized data informing important potential uses of solithromycin and fusidic acid with two late breakers and eight overall presentations at the conference, said David Oldach, M.D., chief medical officer of Cempra.
(www.digitalproducer.com) |
Texas Black Expo Taps Corporate Partners to Give Back to the Community.
Les mer »
Houston Non-Profit Celebrates 14 Years with Scholarship Giveaways, Empowerment Seminars, Kids Adventure Zone, Local Artists Competition and Celebrity Guest Golden Brooks.
(www.digitalproducer.com) |
Motorisk utvikling hos barn.
Les mer »
Det kan Monika Haga og Cathrine Herneblad-Due fortelle.
(Klikk.no - kropp og helse) |
AAP: Group Decisions Benefit Kids With Disabilities.
Les mer »
Shared decision making supports both the child/family and clinician.
(MedPage Today) |
Variety 424631883 The Latest: Prosecutor says nurse could have killed dozens.
Les mer »
Share on: Share on LinkedIn Share on Google+ Share on Pinterest.
(www.startribune.com) |
Handling Patients and Performance Enhancers.
Les mer »
Even without evidence-based steroid treatment protocol.
(MedPage Today) |
- Grunnlaget for SNR er akkurat som før.
Les mer »
Espen Remme er forundret over den pågående diskusjonen.
(Romsdals Budstikke) |
Lawsuit: State should have prevented toddler's beating.
Les mer »
Kirkland foster mother already pleaded guilty to assault.
(seattlepi.com) |
FDA Breaks New Ground with Expanded Keytruda Indication.
Les mer »
Pembrolizumab for genetic defect, not tumor type.
(MedPage Today) |
Pediatricians Need to Address Gun Violence.
Les mer »
Earn Free CME Credits by reading the latest medical news in your specialty.
(MedPage Today) |
First Patient Enrolled in Mallinckrodt Phase 4 Trial of H.P. Acthar® Gel (Repository Corticotropin Injection) for Multiple Sclerosis Relapse.
Les mer »
-- Mallinckrodt's OPTIONS Trial to Assess Efficacy and Safety of H.P. Acthar Gel in Patients with Relapsing-Remitting Multiple Sclerosis - -.
(www.digitalproducer.com) |
Experience a Saturday Like No Other at the 5th Annual Race for Every Child on October 21.
Les mer »
Registration Now Open for 5K run/walk and Kids Dash to Raise Critical Funds for Childrens National Health System.
(www.digitalproducer.com) |
AAP: No Fruit Juice for Infants.
Les mer »
Risks of excessive weight gain, tooth decay too great.
(MedPage Today) |
Wise Buy? Proton Beam Therapy.
Les mer »
It helps only a few, and at a wildly extravagant cost.
(MedPage Today) |
Spesialistutdanning for leger.
Les mer »
Ny spesialistutdanning for leger er en kvalitetsreform med ny modell for spesialitetsstruktur og spesialistutdanning og med endret ansvar, roller og oppgaver for de regionale helseforetakene, helseforetakene, Helsedirektoratet, universitetene, kommunene og Legeforeningen.
(Helse Midt-Norge RHF) |
Santhera informiert über den Zeitrahmen des Zulassungsantrags für Raxone® für die Indikation Duchenne-Muskeldystrophie in Europa.
Les mer »
- Santhera Pharmaceuticals, ein auf die Entwicklung innovativer Medikamente zur Behandlung seltener neuromuskulärer und mitochondrialer Krankheiten fokussiertes Spezialitätenpharmaunternehmen, gibt einen aktualisierten Zeitrahmen für die derzeit laufende Beurteilung ihres Erweiterungsantrags für Raxone.
(inpublic.globenewswire.com) |
Santhera Provides Update on Timeline for Application of Raxone® in Duchenne Muscular Dystrophy in Europe.
Les mer »
- Santhera Pharmaceuticals, a specialty pharmaceutical company focused on the development of innovative treatments for rare mitochondrial and neuromuscular diseases, announces an updated timeline for the ongoing assessment by the Committee for Medicinal Products for Human Use of its extension application for Raxone.
(inpublic.globenewswire.com) |
Is Medicine Still a Black Art?
Les mer »
Christopher Johnson, MD, on the limitations of evidence-based medicine.
(MedPage Today) |
First In Vivo Human Genome Editing to Be Tested in New Clinical Trial.
Les mer »
Sangamo Therapeutics will use zinc finger nucleases to introduce the gene for a missing clotting factor into the livers of men with hemophilia B.
(The Scientist) |
Bellicum Announces Clinical Presentations at the 22nd Congress of the European Hematology Association.
Les mer »
Overall-cohort abstract on BPX-501 selected for presentation at Presidential Symposium.
(www.digitalproducer.com) |
Novartis data at ASCO, ICML and EHA meetings demonstrate meaningful advancements in cancer care.
Les mer »
® pivotal Phase III MONALEESA-2 trial in hormone receptor positive, human epidermal growth factor receptor-2 negative advanced breast cancer to be presented at ASCO.
(inpublic.globenewswire.com) |
New Approaches Help Babies Get Through Opioid Withdrawal.
Les mer »
Earn Free CME Credits by reading the latest medical news in your specialty.
(MedPage Today) |
William Shatners Priceline.com Hollywood Charity Horse Show Sponsored by Wells Fargo Returns June 3 with Special Musical Guest Nancy Wilsons Roadcase Royale.
Les mer »
For nearly three decades, prominent actor and equine lover William Shatner has taken on perhaps his most significant role, not on TV or in film, but in real life as a tireless advocate for underrepresented communities, raising tens of millions of dollars to support hundreds of worthy charitable organizations by way of his annual philanthropic horse show event.
(www.digitalproducer.com) |
Loxo Oncology Announces Details of Two Larotrectinib Clinical Data Oral Presentations at the 2017 American Society of Clinical Oncology Annual Meeting.
Les mer »
Company to Host Conference Call and Webcast on Sunday, June 4 th at 5:30PM CT.
(www.digitalproducer.com) |
NeuroBreak: Sarepta Meets FDA Again; Praise for Valbenazine Trials.
Les mer »
News and commentary from the world of neurology and neuroscience.
(MedPage Today) |
Santhera to Present Data and Host Symposium on Pulmonary Function in Duchenne Muscular Dystrophy at the American Thoracic Society 113th Annual Conference.
Les mer »
Santhera Pharmaceuticals, a specialty pharmaceutical company focused on the development of innovative treatments for rare mitochondrial and neuromuscular diseases, announces that two posters with data from the positive phase III DELOS trial in patients with Duchenne muscular dystrophy will be presented at the 113 th.
(inpublic.globenewswire.com) |
|Om Viddi.no | Kontakt oss på support (a) viddi.no | Copyright® - 2006 Viddinews AS |